After months of intrigue and intense political jockeying, the European Council voted on Monday to relocate Europe’s top medicines regulator to Amsterdam from London.
The close vote — a coin toss was needed — means the European Medicines Agency is likely to encounter less disruption than if Milan, the runner-up, had been chosen. A recent survey of agency staffers favored Amsterdam for its superior international flight service and schools, suggesting the EMA will be able to retain enough staff to maintain regular activities during the upcoming transition.
About the Author Reprints
